Taiwan FDA registration 9bcdbee17e1206f446a175eedd492f6c
Sugar Instant Test Blood Glucose Test System
TW: 糖立測血糖測試系統
Taiwan·Risk Class 2·Taibo Technology Co., Ltd. five-stock factory·Registered Jan 23, 2024 – Jan 23, 2029ActiveRegistration details
- Analysis ID
- 9bcdbee17e1206f446a175eedd492f6c
Company information
- Manufacturer
- Taibo Technology Co., Ltd. five-stock factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- TAIDOC TECHNOLOGY CORPORATION
Product details
- Intended Use
- This product is an in vitro diagnostic medical device, which can quantitatively detect glucose concentration in the blood, and can use fresh fingertip microvascular whole blood, which is suitable for self-measurement and blood glucose monitoring of diabetic patients.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Jan 23, 2024
- Expiry Date
- Jan 23, 2029
About this record
Access comprehensive regulatory information for Sugar Instant Test Blood Glucose Test System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9bcdbee17e1206f446a175eedd492f6c and manufactured by Taibo Technology Co., Ltd. five-stock factory. The authorized representative in Taiwan is TAIDOC TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices